Presentation and Q&A session scheduled for post-market on
Monday, March 28, 2022
BOSTON, March 17,
2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the
leading horizontal platform for cell programming, announced today
that it plans to host a presentation and Q&A session reviewing
business performance for the fourth quarter and full year ended
December 31, 2021, on Monday, March 28, 2022, beginning at 4:30 p.m. ET.
The presentation details and webcast registration link will be
available on Ginkgo's investor relations website at
https://investors.ginkgobioworks.com and a replay will be made
available.
To ask a question ahead of the presentation, please submit them
to @Ginkgo on Twitter (hashtag #GinkgoResults) or by sending an
e-mail to investors@ginkgobioworks.com.
Ginkgo also announced today that the 2022 Annual Meeting of
Shareholders will be held Friday, June 10,
2022, at 2:00 p.m. ET.
Shareholders may participate in the virtual meeting online, vote
their shares electronically and submit live questions by following
the instructions in their proxy materials. Shareholders of record
as of April 14, 2022 will be entitled
to notice of, and to attend and vote at, the Annual Meeting.
About Ginkgo Bioworks
Ginkgo is building a platform to enable customers to program
cells as easily as we can program computers. The company's platform
is enabling biotechnology applications across diverse markets, from
food and agriculture to industrial chemicals to pharmaceuticals.
Ginkgo has also actively supported a number of COVID-19 response
efforts, including K-12 pooled testing, vaccine manufacturing
optimization and therapeutics discovery. For more information,
visit https://www.ginkgobioworks.com/.
Ginkgo Bioworks Contacts:
INVESTOR
CONTACT:
investors@ginkgobioworks.com
MEDIA
CONTACT:
press@ginkgobioworks.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-fourth-quarter-and-full-year-2021-results-presentation-and-date-for-annual-meeting-of-shareholders-301505006.html
SOURCE Ginkgo Bioworks